The Role of IV Infusion Therapy in Slowing the Progression of Multiple Sclerosis

Understanding Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease  in which the immune system mistakenly attacks the protective covering of nerve fibres (myelin) in the brain and spinal cord. This damage disrupts communication between the brain and the rest of the body, leading to symptoms such as muscle weakness, numbness, fatigue, vision problems, and difficulties with balance and coordination

MS is a progressive disease, meaning symptoms can worsen over time. While there is currently no cure, treatments such as IV infusion therapy play a vital role in managing symptoms and slowing disease progression.

How IV Infusion Therapy Helps in MS

IV infusion therapy delivers medicines and supportive treatments directly into the bloodstream. For MS, it is particularly effective because:

  • High bioavailabilityEfficient delivery  Infusion allows direct entry of biologic medications into the bloodstream, ensuring rapid and consistent therapeutic effects.
  • Targeted delivery – Disease-modifying drugs reach the bloodstream directly and act quickly.
  • Long-term benefits – Regular infusion therapy can help reduce relapse rates and slow progression.

 

MS patient seated comfortably during infusion session
Infusion drip bag prepared for MS biologic treatment

Biologics and Disease-Modifying Therapies for MS

One of the most significant advances in MS treatment has been the development of biologics and disease-modifying therapies (DMTs). Many of these are given through IV infusion, helping to:

  • Reduce the frequency and severity of relapses
  • Slow the accumulation of lesions in the central nervous system
  • Preserve mobility and neurological function
  • Delay long-term disability

Commonly used infusion treatments for MS include monoclonal antibodies such as ocrelizumab, natalizumab, and alemtuzumab.

Supportive Infusion Therapies for MS Patients

While not disease-modifying, supportive IV therapies can help manage certain symptoms and improve daily wellbeing when used alongside primary MS treatments. These include:

  • IV nutrient therapy – May help alleviate fatigue and support energy levels, especially in patients with nutritional deficiencies or increased metabolic demand.
  • Hydration therapy – Supports hydration status, which can help reduce medication side effects like headaches or dizziness.
  • Adjunct immune support – Carefully selected supplements or therapies may assist in maintaining overall immune balance, under physician supervision.

What Patients Can Expect During MS Infusion Therapy

Treatment is typically carried out in a specialised infusion centre under medical supervision. Patients are seated comfortably while an IV line is placed and the medication is delivered over a period of time — ranging from one to several hours, depending on the drug.

Sessions may be scheduled every few weeks or months, depending on the treatment plan. Patients are monitored for side-effects and supported by healthcare professionals throughout the process.

The Future of Infusion Therapy in MS Care

Research into MS continues to expand, with new biologic drugs and precision infusion therapies being developed. The future of MS care lies in combining disease-modifying infusions with supportive IV treatments to improve both long-term disease outcomes and daily quality of life.

IV Infusion Therapy for Multiple Sclerosis: A Path to Better Outcomes

For those living with MS, IV infusion therapy represents more than a treatment — it is a way to maintain independence, preserve neurological function, and slow the progression of disease. With ongoing medical advances, infusion therapy is set to play an even greater role in helping MS patients live fuller, healthier lives. At IV One Riyadh, we offer professional IV therapy for MS patients.

Frequently Asked Questions

Q: How does IV infusion therapy slow MS progression?

A: By delivering disease-modifying drugs directly into the bloodstream, infusion therapy reduces relapses, slows lesion development, and preserves neurological function.

A: Monoclonal antibodies such as ocrelizumab, natalizumab, and alemtuzumab are widely used to treat MS through infusion.

A: Yes, when given under medical supervision. Patients are closely monitored during and after infusions to manage any side-effects.

A: Treatment schedules vary . Some infusions are administered every few weeks, while others may be given once or twice a year depending on the prescribed drug.

A: No, infusion therapy does not cure MS, but it is highly effective in slowing disease progression, reducing relapses, and improving quality of life.

Enquire Now